Infectious Risks and Optimal Strength of Maintenance Immunosuppressants in Rituximab-Treated Kidney Transplantation

BACKGROUND: Rituximab, an anti-CD20 antibody, effectively depletes B lymphocytes. It is not clear whether the use of conventional doses of mycophenolate mofetil (MMF), methylprednisolone and tacrolimus as maintenance immunosuppression in rituximab-treated kidney transplantation is associated with in...

詳細記述

保存先:
書誌詳細
主要な著者: Baek, Chung Hee, Yang, Won Seok, Park, Kyung Sun, Han, Duck Jong, Park, Jae Berm, Park, Su-Kil
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger AG 2012
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350352/
https://ncbi.nlm.nih.gov/pubmed/22619669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000337339
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料